Presentation TCT 2016 Individualizing Care: Which Patients Might Benefit From Prolonged DAPT? Who Might Be Harmed? Presenter: Robert W. Yeh October 30, 2016 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2016 CAD Pharma Up Next Presentation TCT 2016 Low-Risk Studies: Design and Updates I - The UK All-Comer TAVI Study Presenter: Neil E. Moat October 30, 2016 More slides + Presentation TCT 2016 Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial Presenter: Jeffrey J. Popma October 30, 2016 Presentation TCT 2016 Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World Presenter: Christopher B. Granger October 30, 2016 We Recommend
Presentation TCT 2016 Low-Risk Studies: Design and Updates I - The UK All-Comer TAVI Study Presenter: Neil E. Moat October 30, 2016
Presentation TCT 2016 Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial Presenter: Jeffrey J. Popma October 30, 2016
Presentation TCT 2016 Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World Presenter: Christopher B. Granger October 30, 2016